Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.
Denver Public Health, Denver Health and Hospital Authority, Denver, Colorado, USA.
Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S65-S73. doi: 10.1093/cid/ciab330.
Nasopharyngeal specimens (NPS) are commonly used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing but can be uncomfortable for patients. Self-collected saliva specimens (SS) or anterior nasal specimens (ANS) for SARS-CoV-2 detection are less invasive, but the sensitivity of these specimen types has not been thoroughly evaluated.
During September-November 2020, 730 adults undergoing SARS-CoV-2 testing at community testing events and homeless shelters in Denver provided self-collected SS and ANS before NPS collection and answered a short survey about symptoms and specimen preference. Specimens were tested for SARS-CoV-2 by means of real-time reverse-transcription polymerase chain reaction (rRT-PCR); viral culture was performed on a subset of specimens positive by rRT-PCR. The sensitivity of SS and ANS for SARS-CoV-2 detection by rRT-PCR was measured against that of NPS. Subgroup analyses included test outcomes by symptom status and culture results.
Sensitivity for SARS-CoV-2 detection by rRT-PCR appeared higher for SS than for ANS (85% vs 80%) and higher among symptomatic participants than among those without symptoms (94% vs 29% for SS; 87% vs 50% for ANS). Among participants with culture-positive SARS-CoV-2 by any specimen type, the sensitivities of SS and ANS by rRT-PCR were 94% and 100%, respectively. SS and ANS were equally preferred by participants; most would undergo NPS collection again despite this method's being the least preferred.
SS were slightly more sensitive than ANS for SARS-CoV-2 detection with rRT-PCR. With both SS and ANS, SARS-CoV-2 was reliably detected among participants with symptoms. Self-collected SS and ANS offer practical advantages, are preferred by patients, and might be most useful for testing people with coronavirus disease 2019 symptoms.
鼻咽拭子(NPS)常用于严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)检测,但可能会令患者感到不适。采集自患者自身的唾液样本(SS)或前鼻拭子(ANS)进行 SARS-CoV-2 检测的侵入性较小,但这些样本类型的敏感性尚未得到彻底评估。
2020 年 9 月至 11 月期间,在丹佛市的社区检测活动和收容所中进行 SARS-CoV-2 检测的 730 名成年人在采集 NPS 之前采集了自身的 SS 和 ANS,并回答了一份有关症状和样本偏好的简短调查问卷。通过实时逆转录聚合酶链反应(rRT-PCR)对样本进行 SARS-CoV-2 检测;对 rRT-PCR 阳性的部分样本进行病毒培养。测量了 SS 和 ANS 检测 rRT-PCR 检测 SARS-CoV-2 的敏感性,并与 NPS 进行了比较。亚组分析包括按症状状态和培养结果进行的检测结果。
rRT-PCR 检测 SS 对 SARS-CoV-2 的敏感性似乎高于 ANS(85%对 80%),且在有症状的参与者中高于无症状参与者(SS 为 94%对 29%;ANS 为 87%对 50%)。在任何样本类型均培养出 SARS-CoV-2 的参与者中,SS 和 ANS 通过 rRT-PCR 的敏感性分别为 94%和 100%。参与者对 SS 和 ANS 的偏好程度相同;尽管 NPS 是最不受欢迎的样本采集方法,但大多数人仍会再次接受 NPS 采集。
SS 用于 rRT-PCR 检测 SARS-CoV-2 的敏感性略高于 ANS。通过 SS 和 ANS,都能可靠地检测出有症状的参与者中的 SARS-CoV-2。采集自患者自身的 SS 和 ANS 具有实际优势,受到患者的青睐,并且对于检测患有 2019 年冠状病毒病症状的患者可能最有用。